0001179110-15-009591.txt : 20150611
0001179110-15-009591.hdr.sgml : 20150611
20150611123443
ACCESSION NUMBER: 0001179110-15-009591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150610
FILED AS OF DATE: 20150611
DATE AS OF CHANGE: 20150611
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van den Broek Richard
CENTRAL INDEX KEY: 0001431872
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 15925341
MAIL ADDRESS:
STREET 1: 73 ARCH STREET
STREET 2: 1ST FLOOR
CITY: GREENWICH
STATE: CT
ZIP: 06830
4
1
edgar.xml
FORM 4 -
X0306
4
2015-06-10
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001431872
van den Broek Richard
73 ARCH STREET, 1ST FLOOR
GREENWICH
CT
06830
1
0
0
0
Common Stock
2015-06-10
4
A
0
6500
A
8500
D
Non-Qualified Stock Option (right to buy)
25.41
2015-06-10
4
A
0
10300
0
A
2025-06-10
Common Stock
10300
10300
D
On June 10, 2015, the Company awarded 6,500 shares of the Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option and Incentive plan, subject to time-based forfeiture restrictions.
Represents option granted by the Issuer pursuant to the 2008 Stock Option and Incentive Plan.
Such option vests in four equal installments beginning September 10, 2015.
/s/ Avery W. Catlin, attorney-in-fact for Richard A. van den Broek
2015-06-11